Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials

BACKGROUND: The prospect for targeted therapies in advanced hepatocellular carcinoma (HCC) has dramatically changed since several recent clinical trials have yielded promising results. The number of second-line therapies is increasing, though the consequent challenge is to consider differences betwe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Therap Adv Gastroenterol
Egile Nagusiak: Wang, Dongxu, Yang, Xu, Lin, Jianzhen, Bai, Yi, Long, Junyu, Yang, Xiaobo, Seery, Samuel, Zhao, Haitao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2020
Gaiak:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313339/
https://ncbi.nlm.nih.gov/pubmed/32636928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820932483
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak